Why is Venmax Drugs falling/rising?

As of 13-Oct, Venmax Drugs & Pharmaceuticals Ltd is experiencing a price increase, currently at 20.95, which reflects a change of 0.99 or 4.96% upward. The stock has shown a strong performance today, outperforming its sector by 5.11%. Notably, there has been a significant rise in investor participation, with delivery volume increasing by 119.92% against the 5-day average. While the stock is currently higher than its 5-day moving averages, it remains lower than the 20-day, 50-day, 100-day, and 200-day moving averages. Over the past week, the stock has gained 8.89%, contrasting with a decline of 23.43% over the past month, indicating a recent recovery phase.
In the broader market context, the Sensex has only increased by 0.66% over the past week, highlighting that Venmax's short-term return is significantly stronger than the benchmark. Year-to-date, Venmax has outperformed the Sensex, with a return of 16.13% compared to the benchmark's 5.36%. This suggests that despite recent volatility, the stock is gaining traction among investors, likely due to improved trading activity and liquidity, although specific positive or negative factors impacting the stock's movement were not provided.